Forrest, Iain S. http://orcid.org/0000-0002-5642-422X
Petrazzini, Ben O. http://orcid.org/0000-0001-9789-9371
Duffy, Áine
Park, Joshua K.
O’Neal, Anya J. http://orcid.org/0000-0001-5188-1344
Jordan, Daniel M. http://orcid.org/0000-0002-5318-8225
Rocheleau, Ghislain http://orcid.org/0000-0002-9989-7553
Nadkarni, Girish N. http://orcid.org/0000-0001-6319-4314
Cho, Judy H. http://orcid.org/0000-0002-7959-0466
Blazer, Ashira D.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01-HL155915)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32-GM007280)
Article History
Received: 15 July 2022
Accepted: 5 April 2023
First Online: 25 April 2023
Competing interests
: R.D. reported receiving grants from AstraZeneca, grants and nonfinancial support from Goldfinch Bio, being a scientific co-founder, consultant and equity holder for Pensieve Health, and being a consultant for Variant Bio, all not related to this work. G.N.N. reported being a scientific co-founder, consultant, advisory board member, and equity owner of Renalytix AI, a scientific co-founder and equity holder for Pensieve Health, a consultant for Variant Bio, and receiving grants from Goldfinch Bio and personal fees from Renalytix AI, BioVie, Reata, AstraZeneca, and GLG Consulting. The remaining authors declare no competing interests.